Archives

by in
Entry Author Date Location
Theraclone Secures $14M to Push Antibody Drug Programs 03/25/13 Seattle
Theraclone Sciences Receives $14,000,000 Series B Funding Round 03/25/13 Seattle
Theraclone Sciences Garners $14,000,000 Series B Financing 03/25/13 Seattle
Nevro Obtains $48,000,000 Series C Funding Round 03/07/13 San Francisco
California Stem Cell Agency Shifts Focus to Clinical Treatments 01/31/13 San Francisco
VenBio’s Goodman Builds an Inside Periscope on Biotech Acquisitions 01/23/13 San Francisco
23andMe Lands $50,000,000 Series D Funding 12/11/12 San Francisco
Pfizer Invests in Rhythm to Support Diabetes, Obesity Drug Programs 11/27/12 Boston
Who’s Still Active Among the Early-Stage Biotech VCs? 07/02/12 National
Seventh Sense, Polaris, & More Boston Life Sciences Newsmakers 06/15/12 Boston
Astute Medical Receives $40,400,000 Series C Funding 06/07/12 San Diego
Trivascular Lands $60,000,000 Series D Funding Round 06/05/12 San Francisco
Rhythm Pharmaceuticals Secures $25,000,000 Series B Financing Round 06/04/12 Boston
Sue Siegel Leaves MDV to Run $6B GE Health Unit 05/21/12 San Francisco
SD Life Sciences Roundup: Celladon, Vertex, MediciNova, & More 05/10/12 San Diego
San Diego’s Celladon Extends Round to $53M, Opens European Office 05/08/12 San Diego
Celladon Lands $10,000,000 New Funding Round 05/07/12 San Diego
Radius Health Seeks $86M IPO 02/07/12 Boston
Allozyne “Redistributes” Workforce After Scrapping Poniard Merger Plan 01/03/12 Seattle
Allozyne Raises More VC Cash, Looks to FDA Meeting After Poniard Deal Fizzles 12/23/11 Seattle
Acceleron Pharma Lands $30,000,000 New Financing 12/23/11 Boston
Allozyne Receives New Round 12/23/11 Seattle
Allozyne, Poniard Scrap Plan to Merge Amid Investor Apathy 12/22/11 Seattle
Rhythm Adds Former Merck VP as CEO 11/09/11 Boston
MPM-Backed Rhythm Advances Drug Programs in Diabetes and Obesity 10/25/11 Boston
How Will Your Doctor Use Your Genome? Ask Our Panel Oct. 24 10/12/11 San Francisco
Cardiac Dimensions Wins EU Approval for Heart Failure Device, Aims for Market in 2012 09/29/11 Seattle
Valeritas Raises $150M for Insulin Device 09/13/11 New York
Theraclone Snaps Up $10.6M Financing 09/08/11 Seattle
Theraclone Sciences Secures $10,600,000 Series B Round 09/08/11 Seattle
Page 2 of 7 « previous page · next page »